![Stentrode by Synchron](https://www.implantable-device.com/wp-content/uploads/2019/04/stentrode.jpg)
Image Credit: Synchron
Synchron Inc. announced today the first successful clinical implantation of the Stentrode®, a minimally-invasive neural interface technology, a component of the Synchron Brain-Computer Interface. This is the first clinical feasibility trial evaluating this technology for its potential to restore communication in people with severe paralysis.